Menopause Hormone Therapy (HRT) in Glendale, AZ

Bioidentical hormones in Glendale: what it means

If you are one of the 31,037 women aged 45 to 64 in Glendale and have searched for "bioidentical" hormones: the word means a hormone whose structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

70 OB-GYNs in the federal NPI registry give a primary practice address in Glendale: 28.0 per 100,000 residents, above the US rate of 17.8 and above Arizona's 14.6, and more per resident than 66% of the 924 cities VevaMD covers. Set against the city's 31,037 women aged 45 to 64, that is one OB-GYN for roughly every 440.

Within 10 miles of the city there are 309 OB-GYNs, and within 25 miles 622, about 18.7 per 100,000 of the 3,333,036 residents in that radius. Whether or not you have an OB-GYN, you can ask a physician licensed in Arizona about menopause hormone therapy online from Glendale, with no waiting room.

For women in Glendale, a physician licensed in Arizona can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. VevaMD does not offer pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11